SPARC entered into a licensing agreement with Biomodifying
Sun Pharma Advanced Research Company (SPARC) has entered into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique... Read More
MCQ Self Assessment Tests in Biopharmaceuticals – Biologics and Biosimilar Regulatory Affairs and Strategic Management
MCQ Tests on Biopharmaceuticals – Biologic and Biosimilar Regulatory Affairs and Strategic Management Career in Biopharmaceutical If you look today at global... Read More
Case Study: Curious Case of Remicade bio-pharma patent battle with Inflectra
Posted on22 Aug 2016
Tagsbiopharma patent battle, biopharmaceuticals, Celltrion, Hospira, Inflectra, Johnson & Johnson, pfizer, Remicade, Remicade biosimilar
Comments0
Biopharmaceutical: Infliximab Class: monoclonal antibody Brand Name: Remicade Marketed By: Johnson & Johnson ——————————– Biosimilar of Infliximab is Inflectra. ——————————– Infliximab (trade... Read More
Intas’s Growth Driver : Biopharmaceuticals
Posted on23 Jan 2015
Tagsbiopharmaceuticals, Erykine®, Folisurge®, Intalfa®, Intas, Intas Biologics, Intass Biopharmaceuticals, Mabtas®, Neukine®, Pegasta®, Rituximab, Terifrac®
Comments0
Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas’s success and incessant growth... Read More